Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease -- Ignore unavailable to you. Want to Upgrade?

To: James Strauss who wrote (2354)	4/7/1998 12:11:00 AM
From: Lee Kennedy	Read Replies (1) \| Respond to of 3725

<< The Siemens factor has changed... Awareness keeps growing...>> Hi Jim, Can you believe the action we've had since the Siemens' contract expired on March 31st? (1) Imatron was the subject of a very positive article in the April 6th edition of Newsweek. Because of early distribution, reports on the article were being reported online as early as April 2nd. (2) NBC's Nightly News featured Imatron during the last 7 minutes on Friday night. I didn't see the segment, but understand that Imatron's CEO was interviewed. (3) Imatron may have been mentioned on MSCNBC on Sunday morning I'm not sure of this one. Perhaps someone else was watching. (4) Imatron has done two press releases since April 1st, both discussing recent studies with the Ultrafast CT. I'd say we're off to a good start. I expect to hear and read more about Imatron in the Bristol-Myers Squibb radio and newspaper ads for Pravachol. soon. They were describing the Ultrafast CT scanner in their ads last month but were prohibited from mentioning Imatron. Lee

To: James Strauss who wrote (2354)	4/7/1998 3:35:00 AM
From: Jim Lucky	Read Replies (1) \| Respond to of 3725

It is my understanding that Ultrasound isn't available yet, Imatron is Saving lives is saving lives and it would seem that the market would soon recognize Imatrons technology as the most feasible and effective given the fact that the need is immediate and accuracy will naturally draw interest from the public while insurance companies become pressured to cover the cost at least partially it would seem. This is a time bomb ticking, literally!!! Shares will rise. IMHO Jim Lucky